Immunovant Stock Forecast

Stock Price Forecast

The 8 analysts that cover Immunovant stock have a consensus rating of "Buy" and an average price target of $33, which forecasts a 20.09% increase in the stock price over the next year. The lowest target is $18 and the highest is $50.

Price Target: $33 (+20.09%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$18	$33	$33	$50
Change	-34.50%	+20.09%	+20.09%	+81.95%

Analyst Ratings

The average analyst rating for Immunovant stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	3	3	3	3
Buy	2	2	2	2	2	2
Hold	4	5	4	4	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	10	9	9	9	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Corinne Johnson Goldman Sachs	Goldman Sachs	Hold Maintains $29 → $32	Hold	Maintains	$29 → $32	+16.45%	Apr 15, 2026
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $35	Strong Buy	Reiterates	$35	+27.37%	Feb 10, 2026
Yatin Suneja Guggenheim	Guggenheim	Strong Buy Maintains $41 → $44	Strong Buy	Maintains	$41 → $44	+60.12%	Feb 9, 2026
Danielle Brill Truist Securities	Truist Securities	Hold Maintains $16 → $22	Hold	Maintains	$16 → $22	-19.94%	Jan 8, 2026
Andy Chen Wolfe Research	Wolfe Research	Hold → Buy Upgrades $50	Hold → Buy	Upgrades	$50	+81.95%	Jan 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

8.01M

EPS This Year

-2.68

from -2.73

EPS Next Year

-2.68

from -2.68

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	-	-	-	-	-	-	8.01M
Revenue Growth	-	-	-	-	-	-	-
EPS	-1.22	-1.43	-1.71	-1.88	-2.73	-2.68	-2.68
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	90.7M
Avg	n/a	8.0M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-2.64	-2.31
Avg	-2.68	-2.68
Low	-2.70	-3.29

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.